Outlook Therapeutics, Inc. Note Agreements
11 Contracts & Agreements
- Third Amendment to Convertible Promissory Note, dated January 22, 2024 (Filed With SEC on January 24, 2024)
- Amendment, dated December 21, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on December 22, 2023)
- Amendment, dated February 10, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on February 14, 2023)
- Form of Note (Filed With SEC on December 22, 2022)
- Note Amendment dated November 16, 2021 (Filed With SEC on November 16, 2021)
- Promissory Note dated November 16, 2021 (Filed With SEC on November 16, 2021)
- Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021 (Filed With SEC on November 16, 2021)
- Promissory Note dated November 4, 2020 (Filed With SEC on November 6, 2020)
- Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020 (Filed With SEC on November 6, 2020)
- Form of Senior Secured Promissory Note (Filed With SEC on December 23, 2019)
- Third Note Amendment dated June 28, 2019 (Filed With SEC on July 1, 2019)
